Clinician views on treatments and research for first-episode psychosis in 14–18-year-olds

Background Limited research explores clinician perspectives on treatments for children and young people (CYP) experiencing first-episode psychosis (FEP), and clinician views on involving CYP in clinical trials. Understanding these perspectives can inform service development and research design.Method A survey was completed by 116 clinicians working in Early Intervention in Psychosis (EIP) and Child and Adolescent Mental Health Services. It captured treatment preferences between antipsychotic medication (AP), cognitive behavioural therapy, and family therapy (FT); preferred trial designs; and outcome priorities. Responses were analysed using Kruskal−Wallis tests for group differences and content analysis for open responses.Results AP was most frequently offered (M = 72.14; SD = 37.54) but rated least helpful (M = 65.95; SD = 23.20). FT was considered the most helpful standalone intervention (M = 74.51; SD = 21.43), though least often provided (M = 51.48; SD = 39.25; p < 0.01). Clinicians identified the combination of CBT, FT and AP as most helpful overall (M = 83.29; SD = 19.40). They preferred flexible trial designs allowing movement between treatment arms. Coping and recovery were key outcome priorities.Discussion The study highlights a disconnect between treatments commonly offered and those viewed as most effective, with attitudes and beliefs likely to influence practice and willingness to support trials. Differing views demonstrate the need for further research to guide improvements in services for CYP with FEP.